You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
達嘉維康(301126.SZ):部分在研產品依折麥布阿託伐他汀鈣片已完成穩定性研究及BE試驗

格隆匯6月3日丨達嘉維康(301126.SZ)在投資者互動平臺表示,公司旗下擁有達嘉生物製藥、天濟草堂兩家製藥企業。公司醫藥工業業務主要圍繞藥品研發、醫療器械、食品等的生產加工。公司部分在研產品依折麥布阿託伐他汀鈣片已完成穩定性研究及BE試驗;沙庫巴曲纈沙坦鈉片進入技術審評階段;阿奇黴素幹混懸劑(0.1g)已完成申報正在審評中;諾氟沙星膠囊(規格:0.1g)已完成小試研究;諾氟沙星原料藥正在進行中試研究。具體研發進展敬請關注公司發佈的相關公告。公司持續看好創新藥的發展潛力和市場前景,密切關注並探索佈局的可行性,完善產業鏈佈局,努力提升公司的綜合競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account